Deltex Medical Group PLC Director Dealing (7196Y)

TIDMDEMG

RNS Number : 7196Y

Deltex Medical Group PLC

23 August 2018

23 August 2018

Deltex Medical Group plc

("Deltex Medical" or the "Company")

Director Dealing

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), was informed yesterday that Nigel Keen, Chairman of the Company, purchased 2,000,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 0.8 pence per Ordinary Share and 1,000,000 Ordinary Shares at a price of 0.85 pence per Ordinary Share on 21 August 2018. On 22 August 2018, 1,000,000 Ordinary Shares at a price of 0.9 pence per Ordinary Share were also purchased.

Following these transactions, Mr Keen's beneficial ownership is 52,223,410 Ordinary Shares, representing approximately 10.6 per cent. of Deltex Medical's issued ordinary share capital.

Mr Keen also transferred 6,000,000 Ordinary Shares into the Imperialise Limited Pension Fund on 23 August 2018. Mr Keen is the principal beneficiary of this fund and following this transaction, his beneficial interest in the Company remains unchanged from that stated above.

For further information, please contact:-

 
 Deltex Medical Group            01243 774 837 
  plc                             [e-mail] 
 Nigel Keen, Chairman 
 Andy Mears, Chief Executive 
 Jonathan Shaw, Group 
  Finance Director 
 
 Nominated Adviser & 
  Broker 
 Arden Partners plc              020 7614 5900 
 Chris Hardie 
  Ciaran Walsh 
 
 Joint Broker 
 Turner Pope Investments         0203 621 4120 
  (TPI) Ltd                       [e-mail] 
 Andy Thacker 
 
   Financial Public Relations 
 IFC Advisory                    0203 934 6630 
 Tim Metcalfe 
  Graham Herring 
  Heather Armstrong 
 
 

Notes for Editors

Deltex Medical manufactures and markets haemodynamic monitoring technologies. Deltex Medical's proprietary ODM (TrueVue(TM) Doppler) is the only technology to measure blood flow in the central circulation in real time. Minimally invasive, easy to set up and quick to focus, the technology generates a low-frequency ultrasound signal, which is highly sensitive to changes in flow and measures them immediately. Deltex has been the only group in the enhanced haemodynamic space to build a robust and credible evidence base proving the clinical and economic benefits of its core technology, TrueVue(TM) Doppler, which is proven to reduce complications suffered by patients after surgery and save hospitals the costs of treating those complications.

Deltex Medical's TrueVue(TM) System on the CardioQ-ODM+ monitor platform also now provides clinicians with two further advanced haemodynamic monitoring technologies. High Definition Impedance Cardiography (TrueVue(TM) Impedance) is an entirely non-invasive monitoring technology which creates an electrical field across the chest and measures the disruption to this field when the heart pumps blood. Pulse Pressure Waveform Analysis

(TrueVue(TM) Pressurewave) uses peripheral blood pressure signal analysis to give doctors information on changes in the circulation and is particularly suited to monitoring lower risk or haemodynamically stable patients.

Group goal

Haemodynamic management is now becoming widely accepted as an important major new medical modality. Consequently, the Group's focus is on maximising value from the opportunities presented, as enhanced haemodynamic management is adopted into routine clinical practice around the world. The Group aims to provide clinicians with a single platform, a 'haemodynamic workstation', which offers them a range of technologies from simple to sophisticated to be deployed according to the patient's condition as well as the skill and expertise of the user. Doing this will enable the Group to partner healthcare providers to support modern haemodynamic management across the whole hospital.

The Group is currently in the implementation phase of achieving this goal in a number of territories worldwide, operating directly in the UK, USA, Spain and Canada and through distribution arrangements in a further 30 countries.

Note: This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated with them.

 
       Details of the person discharging managerial 
   1    responsibilities / person closely associated 
----  ---------------------------------------------------------- 
 a)    Names                  Nigel Keen - Chairman 
----  ---------------------  ----------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------- 
 a)    Position/status        See 1(a) above for position - 
                               classified as a PDMR of Deltex 
                               Medical 
----  ---------------------  ----------------------------------- 
 b)    Initial notification   Initial 
        /Amendment 
----  ---------------------  ----------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------- 
 a)    Name                   Deltex Medial Group plc 
----  ---------------------  ----------------------------------- 
 b)    LEI                    213800XN34P6LI8J6M39 
----  ---------------------  ----------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ---------------------------------------------------------- 
 a)    Description            Ordinary shares of 1 penny each 
        of the financial       ("Ordinary Shares") 
        instrument, 
        type of instrument 
----  ---------------------  ----------------------------------- 
 b)    Identification         GB0059337583 
        code 
----  ---------------------  ----------------------------------- 
 c)    Nature of the          Purchase of Ordinary Shares 
        transaction 
----  ---------------------  ----------------------------------- 
 d)    Price(s) and            Prices(s)    Volume(s) 
        volume(s)              -----------  ---------- 
                                0.8 pence    2,000,000 
                               -----------  ---------- 
----  ---------------------  ----------------------------------- 
 d)    Aggregated 
        information 
        - Aggregated 
        volume                 2,000,000 
        - Price 
                               0.8 pence 
----  ---------------------  ----------------------------------- 
 e)    Date of the 
        transaction            21 August 2018 
----  ---------------------  ----------------------------------- 
 f)    Place of the 
        transaction            London Stock Exchange, AIM Market 
                               (XLON) 
----  ---------------------  ----------------------------------- 
 
 
       Details of the person discharging managerial 
   1    responsibilities / person closely associated 
----  ---------------------------------------------------------- 
 a)    Names                  Nigel Keen - Chairman 
----  ---------------------  ----------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------- 
 a)    Position/status        See 1(a) above for position - 
                               classified as a PDMR of Deltex 
                               Medical 
----  ---------------------  ----------------------------------- 
 b)    Initial notification   Initial 
        /Amendment 
----  ---------------------  ----------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------- 
 a)    Name                   Deltex Medial Group plc 
----  ---------------------  ----------------------------------- 
 b)    LEI                    213800XN34P6LI8J6M39 
----  ---------------------  ----------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ---------------------------------------------------------- 
 a)    Description            Ordinary shares of 1 penny each 
        of the financial       ("Ordinary Shares") 
        instrument, 
        type of instrument 
----  ---------------------  ----------------------------------- 
 b)    Identification         GB0059337583 
        code 
----  ---------------------  ----------------------------------- 
 c)    Nature of the          Purchase of Ordinary Shares 
        transaction 
----  ---------------------  ----------------------------------- 
 d)    Price(s) and            Prices(s)     Volume(s) 
        volume(s)              ------------  ---------- 
                                0.85 pence    1,000,000 
                               ------------  ---------- 
----  ---------------------  ----------------------------------- 
 d)    Aggregated 
        information 
        - Aggregated 
        volume                 1,000,000 
        - Price 
                               0.85 pence 
----  ---------------------  ----------------------------------- 
 e)    Date of the 
        transaction            21 August 2018 
----  ---------------------  ----------------------------------- 
 f)    Place of the 
        transaction            London Stock Exchange, AIM Market 
                               (XLON) 
----  ---------------------  ----------------------------------- 
 
 
       Details of the person discharging managerial 

   1    responsibilities / person closely associated 
----  ---------------------------------------------------------- 
 a)    Names                  Nigel Keen - Chairman 
----  ---------------------  ----------------------------------- 
 2     Reason for the notification 
----  ---------------------------------------------------------- 
 a)    Position/status        See 1(a) above for position - 
                               classified as a PDMR of Deltex 
                               Medical 
----  ---------------------  ----------------------------------- 
 b)    Initial notification   Initial 
        /Amendment 
----  ---------------------  ----------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ---------------------------------------------------------- 
 a)    Name                   Deltex Medial Group plc 
----  ---------------------  ----------------------------------- 
 b)    LEI                    213800XN34P6LI8J6M39 
----  ---------------------  ----------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ---------------------------------------------------------- 
 a)    Description 
        of the financial 
        instrument,            Ordinary shares of 1 penny each 
        type of instrument     ("Ordinary Shares") 
----  ---------------------  ----------------------------------- 
 b)    Identification         GB0059337583 
        code 
----  ---------------------  ----------------------------------- 
 c)    Nature of the 
        transaction            Purchase of Ordinary Shares 
----  ---------------------  ----------------------------------- 
 d)    Price(s) and            Prices(s)    Volume(s) 
        volume(s)              -----------  ---------- 
                                0.9 pence    1,000,000 
                               -----------  ---------- 
----  ---------------------  ----------------------------------- 
 d)    Aggregated 
        information 
        - Aggregated 
        volume                 1,000,000 
        - Price 
                               0.9 pence 
----  ---------------------  ----------------------------------- 
 e)    Date of the 
        transaction            22 August 2018 
----  ---------------------  ----------------------------------- 
 f)    Place of the 
        transaction            London Stock Exchange, AIM Market 
                               (XLON) 
----  ---------------------  ----------------------------------- 
 
 
       Details of the person discharging managerial 
   1    responsibilities / person closely associated 
----  -------------------------------------------------------- 
 a)    Names                  Nigel Keen - Chairman 
----  ---------------------  --------------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------- 
 a)    Position/status        See 1(a) above for position - 
                               classified as a PDMR of Deltex 
                               Medical 
----  ---------------------  --------------------------------- 
 b)    Initial notification   Initial 
        /Amendment 
----  ---------------------  --------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------- 
 a)    Name                   Deltex Medial Group plc 
----  ---------------------  --------------------------------- 
 b)    LEI                    213800XN34P6LI8J6M39 
----  ---------------------  --------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------- 
 a)    Description 
        of the financial 
        instrument,            Ordinary shares of 1 penny each 
        type of instrument     ("Ordinary Shares") 
----  ---------------------  --------------------------------- 
 b)    Identification         GB0059337583 
        code 
----  ---------------------  --------------------------------- 
 c)    Nature of the 
        transaction            Share Transfer 
----  ---------------------  --------------------------------- 
 d)    Price(s) and            Prices(s)    Volume(s) 
        volume(s)              -----------  ---------- 
                                Nil          6,000,000 
                               -----------  ---------- 
----  ---------------------  --------------------------------- 
 d)    Aggregated 
        information 
        - Aggregated 
        volume                 6,000,000 
        - Price 
                               Nil 
----  ---------------------  --------------------------------- 
 e)    Date of the 
        transaction            23 August 2018 
----  ---------------------  --------------------------------- 
 f)    Place of the 
        transaction            Off market transaction 
----  ---------------------  --------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHLLFSLTSIVFIT

(END) Dow Jones Newswires

August 23, 2018 07:50 ET (11:50 GMT)